中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

乳腺癌分子分型与治疗策略

赵    毅,邓    鑫   

  1. 中国医科大学附属盛京医院胰腺乳腺外科,辽宁沈阳110004
  • 出版日期:2015-07-01 发布日期:2015-06-30

  • Online:2015-07-01 Published:2015-06-30

摘要:

随着乳腺癌早期诊断及综合治疗水平的提高,乳腺癌发病率日趋升高,其病死率虽有所下降,但仍是女性病死率最高的致死性疾病。相同病理类型及相同临床分期的乳腺癌,即使经历相同的治疗过程其预后仍然有较大差异,表明乳腺癌存在高度的异质性。作为分子高度异质性疾病,沿用的解剖学分期和组织学分类已不能满足其目前的临床诊治需求,尤其缺少能够标志肿瘤生物学行为并对临床治疗提供指导作用的乳腺癌组织学分类方法。分子水平联合组织学分类研究乳腺癌的发病机制、治疗及预后成为当前的研究热点,标志着乳腺癌的治疗进入到个体化治疗的时代。

关键词: 乳腺癌, 分子分型, 个体化治疗

Abstract:

Biological subtype of breast cancer and treatment as well as prognosis        ZHAO Yi, DENG Xin. Department of Pancreatic and Breast Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China
Corresponding author: ZHAO Yi, E-mail: zhaoy5@sj-hospital.org
Abstract    With the development of early diagnosis and comprehensive treatment for breast cancer, the incidence of breast cancer is rising. Though the mortality of breast cancer declines, it remains one of the deadly diseases for woman. The prognosis of breast cancer with the same pathology type and clinical stage differs greatly even the treatment is same. It suggests highly heterogenicity of the breast cancer. The simply TNM stage based on anatomy and histology grade is not sufficient for the current breast cancer treatment. Especially need for breast cancer biological subtype based on molecular level which can suggest the clinical behavior and guide the treatment is the current research focus. It indicates that the treatment of breast cancer has entered the age of advocating individualized treatment on the basis of the standard multidisciplinary treatment. 

Key words: breast cancer, biological subtype, individualized treatment